Treatment of the WEHI-2131 or CH31 B cell lymphomas with anti-mu or transforming growth factor (TGF)-beta leads to growth inhibition and subsequent cell death via apoptosis. Since anti-mu stimulates a transient increase in c-myc and c-fos transcription in these lymphomas, we examined the role of these proteins in growth regulation using antisense oligonucleotides. Herein, we demonstrate that antisense oligonucleotides for c-myc prevent both anti-mu- and TGF-beta-mediated growth inhibition in the CH31 and WEHI-231 B cell lymphomas, whereas antisense c-fos has no effect. Furthermore, antisense c-myc promotes the appearance of phosphorylated retinoblastoma protein in the presence of anti-mu and prevents the progression to apoptosis as measured by propidium iodide staining. Northern and Western analyses show that c-myc message and the levels of multiple myc proteins were maintained in the presence of antisense c-myc, results indicating that myc species are critical for the continuation of proliferation and the prevention of apoptosis. These data implicate c-myc in the negative signaling pathway of both TGF-beta and anti-mu.
Skip Nav Destination
Article navigation
1 January 1994
Article|
January 01 1994
Lymphoma models for B cell activation and tolerance. X. Anti-mu-mediated growth arrest and apoptosis of murine B cell lymphomas is prevented by the stabilization of myc.
G Fischer,
G Fischer
Immunology Division, University of Rochester School of Medicine and Dentistry, New York 14642.
Search for other works by this author on:
S C Kent,
S C Kent
Immunology Division, University of Rochester School of Medicine and Dentistry, New York 14642.
Search for other works by this author on:
L Joseph,
L Joseph
Immunology Division, University of Rochester School of Medicine and Dentistry, New York 14642.
Search for other works by this author on:
D R Green,
D R Green
Immunology Division, University of Rochester School of Medicine and Dentistry, New York 14642.
Search for other works by this author on:
D W Scott
D W Scott
Immunology Division, University of Rochester School of Medicine and Dentistry, New York 14642.
Search for other works by this author on:
G Fischer
Immunology Division, University of Rochester School of Medicine and Dentistry, New York 14642.
S C Kent
Immunology Division, University of Rochester School of Medicine and Dentistry, New York 14642.
L Joseph
Immunology Division, University of Rochester School of Medicine and Dentistry, New York 14642.
D R Green
Immunology Division, University of Rochester School of Medicine and Dentistry, New York 14642.
D W Scott
Immunology Division, University of Rochester School of Medicine and Dentistry, New York 14642.
Online ISSN: 1540-9538
Print ISSN: 0022-1007
J Exp Med (1994) 179 (1): 221–228.
Citation
G Fischer, S C Kent, L Joseph, D R Green, D W Scott; Lymphoma models for B cell activation and tolerance. X. Anti-mu-mediated growth arrest and apoptosis of murine B cell lymphomas is prevented by the stabilization of myc.. J Exp Med 1 January 1994; 179 (1): 221–228. doi: https://doi.org/10.1084/jem.179.1.221
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement